V
Vivodyne
Vivodyne accelerates the discovery of cures to human diseases with highly scalable drug testing on lab-grown 3D human tissues
About Vivodyne
Vivodyne is a biotechnology company revolutionizing the way scientists study human biology and develop therapeutics. The company focuses on creating preclinical certainty before drugs enter clinical trials, especially as these drugs become more precise and human-specific. Vivodyne achieves this by combining three complex areas: human tissue engineering, highly scalable robotics, and cutting-edge AI models. The company serves pharmaceutical and biotechnology firms looking to enhance their drug discovery processes. Operating in the biotechnology market, Vivodyne's business model involves developing and providing advanced human tissue models that can be used to test drug efficacy before clinical trials. This approach not only accelerates the drug development process but also reduces costs and increases the likelihood of clinical success. Vivodyne generates revenue through the sale of its innovative platforms and services to pharmaceutical companies and research institutions.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2020
- Headquarters
- Brisbane, United States
- Employees
- 41
- Open positions
- 3
- Dealroom signal
- 46.3/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES AOther financing | May 2025 | $40M | $160M | MBX Capital · Helena · Lingotto Investment Management · Fortius Ventures | ↗ |
| SEEDOther financing | Nov 2023 | $38M | $152M | Khosla Ventures · Kairos Ventures · MBX Capital · Bison Ventures | ↗ |
Growth signals
Latest recorded traffic for Vivodyne is 3.5K monthly website visits, down 52.1% over the last three months. Vivodyne's team grew 2.5% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
 Lucia BioBiotech & Life Sciences |
Brisbane, Australia | Operational | 1 | $1.9M | $7.8M |
 Accipiter BiosciencesBiotech & Life Sciences |
Seattle, United States | Operational | |||
 ElephasA live tumor imaging company developing novel cancer diagnostic solutions to predict treatment outcomes and accelerate drug development |
Garrett Park, United States | Operational | |||
 DIADEMImproves clinicians/patient understanding about risk of Dementia/Alzheimer’s to enable earlier decisions and outcome |
London, United Kingdom | Operational | |||
 ResBioticMobilizing an ecosystem of support for the world inside the lungs |
Birmingham, United States | Operational | |||
 FecundisSperm-enhancing technologies increasing infertility treatment success |
Rosario, Argentina | Operational | |||
 Human Life CORDUmbilical cord-derived allogeneic cell therapy development |
Tokyo, Japan | Operational | |||
 Vital BioPoint-of-care blood testing for rapid diagnostic results |
Mississauga, Canada | Operational |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed4 investors entered at this stage
Khosla Ventures
MBX Capital
Bison Ventures- CVCS Ventures
Series A4 investors entered at this stage
Kairos Ventures
Helena
Lingotto Investment Management
Fortius Ventures
Other known investors1 additional known investor
University of Pennsylvania
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Vivodyne on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Vivodyne’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.